Roche Pharmaceutical Development and Sales Overview

Point of Care CER-Constant Exchange Rates CHFbn 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 2022 vs. 2021 CER growth +30% YTD Sep 2020 YTD Sep 2021 Clinical Chem. & Immunodiagn. Coagulation & Urinalysis YTD Sep 2022 Hospital Glucose POC MDX +33% -8% -7% +39% Roche 172

View entire presentation